封面
市場調查報告書
商品編碼
1322078

全球 IVD 品質控制市場 (2023-2030):按產品和服務、用途和製造商類型分類的規模、佔有率、成長分析和預測

Global IVD Quality Control Market Size, Share, Growth Analysis, By Product and Service, By Application, By Manufacturer type - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

IVD品質控制的市場規模將從2021年的10.2億美元成長到2022年的10.6億美元,預測期內年複合成長率為4.1%,預計到2030年將成長到14.6億美元

臨床實驗室、人口老齡化、對外部品質評估項目的需求不斷成長、新興市場中POC儀器的使用不斷增加以及第三方品質控制的增加等因素促進了全球IVD品質控制市場的成長。全球傳染病、愛滋病毒和癌症的增加需要新的診斷方法來進行有效的治療和品質控制以追踪其療效。根據聯合國愛滋病毒/愛滋病聯合規劃署的數據,2019 年估計有 2450 萬愛滋病毒感染者接受了抗逆轉錄病毒治療。由於對快速診斷系統和高品質進化支持的需求不斷成長,市場正在擴大。

許多疾病的患病率正在增加,實驗室檢測的數量也在增加。 2019 年 12 月,COVID-19 的迅速傳播產生了對診斷檢測的巨大需求,許多政府機構建立了眾多實驗室來擴大其臨床檢測能力。這些因素也推動了市場的擴張。

由於各種疾病的增加,醫療器械公司正在專注於使用最先進的技術開發診斷工具。醫院和實驗室越來越傾向於使用即時檢測設備來獲取準確的即時數據,從而增加了對這些設備的需求並推動市場擴張。

在本報告中,我們研究了全球 IVD 品質控制市場,提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律和監管環境、市場規模趨勢和預測以及細分細分市場和區域,總結了主要公司的細分、競爭格局、概況等。

目錄

執行摘要

調查方法

母公司市場分析

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務

關鍵市場洞察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 知識產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 管道產品分析
  • 宏觀經濟指標
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及預測

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 監管狀況
  • 波特的分析
  • Skyquest 對未來顛覆的特別見解

全球 IVD 品質控制市場(按產品和服務)

  • 市場概況
  • 品質控制產品
  • 數據管理解決方案
  • 品質保證服務

全球 IVD 品質控制市場(按用途)

  • 市場概況
  • 臨床化學
  • 免疫化學/免疫測定
  • 分子診斷
  • 凝血/止血
  • 微生物
  • 其他

全球 IVD 品質控制市場,按製造商類型

  • 市場概況
  • 第三方控制製造商
  • OEM

全球 IVD 品質控制市場(按地區)

  • 市場概況
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

競爭格局

  • 前5名企業對比
  • 主要企業市場定位
  • 各大公司的招聘策略
  • 關鍵成功策略
  • 近期市場活動
  • 主要參與者的市場佔有率

主要公司簡介

  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Randox Laboratories
  • Bio-Techne Corporation
  • Or
簡介目錄
Product Code: SQMIG35H2068

IVD Quality Control Market size was valued at USD 1.02 billion in 2021 and is poised to grow from USD 1.06 billion in 2022 to USD 1.46 billion by 2030, growing at a CAGR of 4.1% in the forecast period (2023-2030).

Clinical laboratories, an aging population, rising need for external quality assessment programs, expanding POC instrument use in developed nations, and an increase in third-party quality control are all factors contributing to the growth of the worldwide IVD quality control market. Increased prevalence of infectious diseases, HIV, and cancers worldwide, which call for novel diagnostics for efficient treatment and quality control to track their effectiveness. An estimated 24.5 million HIV patients received antiretroviral therapy in 2019, according to the Joint United Nations Program on HIV and AIDS. The market is expanding as a result of quick diagnosis systems and increased need for high-quality evolution assistance.

Top-down and bottom-up approaches were used to estimate and validate the size of IVD Quality Control and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The market for quality control of in vitro diagnostics (IVD) is divided into product and service, application, manufacturer type, end user, and geography. The IVD Quality Control Market is divided into quality control products, data management solutions, and quality assurance services based on the service and product offered. Clinical chemistry, immunochemistry/immunoassay, hematology, molecular diagnostics, coagulation and hemostasis, microbiology, and others are the different application categories that make up the global market. The global IVD Quality Control Market is segmented into original equipment manufacturers and third-party control manufacturers based on the type of manufacturer. Hospitals, home care settings, clinical laboratories, and academic and research institutes are the different end user segments of the worldwide IVD Quality Control Market.

Driver

Increasing Authorized Clinical Laboratory Across the Globe

The prevalence of numerous diseases is rising, which raises the number of laboratory tests. so that the number of laboratories in the public and private sectors will expand. The rapid growth of COVID-19 in December 2019 created a significant need for diagnostic tests. To expand the capability of laboratory testing, numerous government agencies have set up more laboratories. Consequently, fuel market expansion.

Restraints

Additional Cost and Budget Constraints in Hospital and Laboratories

Investment and experience are required in a hospital to build up a QC procedure. Adoption of QC processes is expensive in clinical laboratories using low volume QC procedures. This reduces the adoption of QC techniques together with budgetary restrictions in many hospitals and laboratories.

Market Trend

Medical device businesses are continually concentrating on the creation of technologically cutting-edge diagnostic tools due to the rising occurrence of diseases. Point-of-care testing devices are increasingly preferred by hospitals and laboratories in order to obtain precise real-time data. As a result, there is a surge in demand for point-of-care testing equipment, which fuels the market's expansion.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global IVD Quality Control Market by Product and Service

  • Market Overview
  • Quality control products
  • data management solutions
  • and quality assurance services.

Global IVD Quality Control Market by Application

  • Market Overview
  • Clinical Chemistry
  • immunochemistry/immunoassay
  • hematology
  • molecular diagnostics
  • coagulation and hemostasis
  • microbiology
  • and others

Global IVD Quality Control Market by Manufacturer type

  • Market Overview
  • Third-party control manufacturers
  • and original equipment manufacturers

Global IVD Quality Control Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Bio-Rad Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Techne Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Or
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments